Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

A2. PK/PD studies

Poster Session: PK/PD Studies

(P-1226) Dose Optimization of β-lactams against Carbapenem-Resistant Pseudomonas from Turkiye Defined as Susceptible to Ceftazidime, Cefepime or Piperacillin/Tazobactam

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT
Location: Halls JK

    Co-Author(s)

  • EB

    Ecem Buyukyanbolu, MD

    Hartford Hospital
    Hartford, Connecticut, United States

    • Presenting Author(s)

  • Christian M. Gill, PharmD

    Infectious Diseases Pharmacy Fellow
    Hartford Hospital
    Hartford, Connecticut, United States

    • Co-Author(s)

  • LG

    Leyla Genc, MD

    Health Sciences University Hamidiye Etfal Training and Research Hospital, Department of Medical Microbiology
    Istanbul, Istanbul, Turkey

  • MK

    Mehmet Karakus, PhD

    Health Sciences University, Department of Medical Microbiology
    Istanbul, Istanbul, Turkey

  • FC

    Fusun Comert, MD

    Bulent Ecevit University, Faculty of Medicine, Department of Medical Microbiology
    Zonguldak, Zonguldak, Turkey

  • BO

    Barış Otlu, Prof.

    Professor
    Malatya İnönü University
    Malatya, Malatya, Turkey

  • EA

    Elif Aktas, MD

    Health Sciences University Hamidiye Etfal Training and Research Hospital, Department of Medical Microbiology
    Istanbul, Istanbul, Turkey

  • DN

    David P. Nicolau, PharmD

    Director
    Hartford Hospital
    Hartford, Connecticut, United States